{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
clindamycin phosphate
to a specific field?
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:cimdelirsen [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04549922: Phase 2 Interventional Completed Covid19
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04516291: Phase 2 Interventional Completed Dyslipidemias
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03070782: Phase 2 Interventional Completed Elevated Lipoprotein(a)
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01940887: Phase 3 Interventional Terminated Age-Related Macular Degeneration
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03974113: Phase 3 Interventional Active, not recruiting Hemophilia
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00932100: Phase 2 Interventional Completed Acute Coronary Syndrome (ACS)
(2009)
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
First approved in 2007
Source:
21 CFR 352
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2016)
Source:
NDA208114
(2016)
Source URL:
First approved in 2016
Source:
NDA208114
Source URL:
Class:
POLYMER
